Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Harmony Gold Mining Co. (HMY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Harmony Gold Mining Co. — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Harmony Gold Mining Co. trades at $16.88 (market cap $10.02B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Harmony Gold Mining Co. pays a 4.63% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Harmony Gold Mining Co. for 45 Days on average.
| HALO | HMY | |
|---|---|---|
Market Cap | $12.58B | $10.02B |
Volume | 2,179,278 | 3,643,683 |
Sector | Health | Basic Materials |
52-Week High | $115.22 | $26.04 |
52-Week Low | $61.63 | $13.32 |
Typical Hold Time | 1 Days | 45 Days |
Enterprise Value | $14.49B | $10.07B |
Dividend Yield | — | 4.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Harmony Gold Mining (HMY) trades at $16.84, up 2.12% today, showing strong profitability with 29.57% net margins and robust cash flow generation. The stock appears fundamentally undervalued with a P/E of 6.02 and EV/EBITDA of 3.54, though technical indicators signal bearish momentum with the price near key support levels. Recent earnings showed mixed results with two beats and two misses, while the company continues its strategic transition toward copper production diversification.
HMY presents a compelling value opportunity given its attractive valuation multiples and strong operational performance, but faces near-term technical headwinds and execution risks in its copper expansion strategy. The bearish technical setup and cautious analyst consensus (70% hold rating) suggest patience may be warranted despite the company's solid fundamentals and record fiscal 2026 results.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Harmony Gold Mining Co.
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
Read more on HMY →
